{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:07:00Z","timestamp":1790154420875,"version":"4.0.1"},"reference-count":17,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"abstract":"<jats:p>Introduction: hepatitis C virus (HCV) screening efficiency in resource-limited settings is compromised by variable ribonucleic acid (RNA) detectability among seropositive individuals. Understanding the demographic predictors of RNA positivity is crucial for optimizing testing algorithms in high-burden populations such as Ethiopia.\n\n \n\nMethods: we conducted a retrospective analysis of 792 anti-HCV seropositive treatment-naive individuals in Ethiopia. Multivariate logistic regression with comprehensive diagnostics was used to assess the independent associations of age and sex with HCV RNA status. Assay specificity was enhanced through duplicate testing and elevated signal-to-cutoff thresholds (S\/CO \u22655.0).\n\n \n\nResults: the overall RNA positivity rate was 69.7% (552\/792). Multivariate analysis revealed that each additional year of age increased the odds of RNA positivity by 3.1% (aOR = 1.031, 95% CI: 1.019-1.042, P &lt;0.001), whereas female sex was independently associated with 44.6% greater odds (aOR = 1.446, 95% CI: 1.060-1.973, P = 0.020). Subgroup analysis revealed that young males (&lt;30 years) had lower RNA positivity (37.8%, 95% CI: 24.1-53.9%) than young females did (50.0%, 95% CI: 36.6-63.4%). RNA positivity was 1.6-fold greater in adults \u226530 years (72.8%) than in younger individuals &lt;30 years (44.8%). Genotype 4 predominated (49.6%) among the RNA-positive cases.\n\n \n\nConclusion: both age and sex independently predict HCV RNA detectability in Ethiopia. The substantially lower RNA positivity among young males suggests that this subgroup may benefit from differentiated testing approaches. Demographic-informed algorithms could optimize resource allocation in HCV elimination programs in low- and middle-income countries (LMICs).<\/jats:p>","DOI":"10.11604\/pamj.2026.53.147.50389","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:37:35Z","timestamp":1790152655000},"source":"Crossref","is-referenced-by-count":0,"title":["Demographic predictors of hepatitis C virus viremia among seropositive individuals in Ethiopia: retrospective analysis and implications for testing algorithms"],"prefix":"10.11604","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3632-0147","authenticated-orcid":false,"given":"Mesfin","family":"Nigussie","sequence":"first","affiliation":[{"name":"International Clinical Laboratories, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3879-876X","authenticated-orcid":false,"given":"Kifle","family":"Tilahun","sequence":"additional","affiliation":[{"name":"International Clinical Laboratories, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"ref0","unstructured":"World Health Organization. Hepatitis C. 2025."},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):533-542. PubMed | Google Scholar","DOI":"10.1038\/s41575-020-0332-6"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet. 2019 Oct 19;394(10207):1451-1466. PubMed","DOI":"10.1016\/S0140-6736(19)32320-7"},{"key":"ref3","unstructured":"Lemoine M, Thursz M. Targeted HCV screening in sub Saharan Africa: a public health imperative. Lancet Gastroenterol Hepatol. 2020;5:436-8."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Sonderup MW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L et al. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. Lancet Gastroenterol Hepatol. 2017 Dec;2(12):910-919. PubMed | Google Scholar","DOI":"10.1016\/S2468-1253(17)30249-2"},{"key":"ref5","unstructured":"Central Statistical Agency of Ethiopia. Population projection of Ethiopia for all regions at Wereda Level from 2014-2017. 2023."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Hundie GB, Raj VS, GebreMichael D, Pas SD, Haagmans BL. Genetic diversity of hepatitis C virus in Ethiopia. PLoS One. 2017 Jun 1;12(6):e0179064. PubMed | Google Scholar","DOI":"10.1371\/journal.pone.0179064"},{"key":"ref7","unstructured":"World Health Organization. Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. 2018. PubMed | Google Scholar"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002 Nov;36(5 Suppl 1):S35-46. PubMed | Google Scholar","DOI":"10.1002\/hep.1840360706"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Cornberg M, Mischke J, Kraft AR, Wedemeyer H. Immunological scars after cure of hepatitis C virus infection: Long-HepC? Curr Opin Immunol. 2023 Jun;82:102324. PubMed | Google Scholar","DOI":"10.1016\/j.coi.2023.102324"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006 Jan;13(1):34-41. PubMed | Google Scholar","DOI":"10.1111\/j.1365-2893.2005.00651.x"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan;59(1):109-20. PubMed | Google Scholar","DOI":"10.1002\/hep.26639"},{"key":"ref12","unstructured":"Iqbal M, McCormick PA, Cannon M, Murphy N, Flanagan P, Kennelly JE et al. Long-term follow-up of patients with spontaneous clearance of hepatitis C: does viral clearance mean cure? Ir Med J. 2017 Jun 9;110(6):582. PubMed | Google Scholar"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Maasoumy B, Wedemeyer H. Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):401-12. PubMed | Google Scholar","DOI":"10.1016\/j.bpg.2012.09.009"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan;59(1):109-20. PubMed | Google Scholar","DOI":"10.1002\/hep.26639"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Villa E, Karampatou A, Camm\u00e0 C, Di Leo A, Luongo M, Ferrari A et al. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastroenterology. 2011 Mar;140(3):818-29. PubMed | Google Scholar","DOI":"10.1053\/j.gastro.2010.12.027"},{"key":"ref16","unstructured":"World Health Organization. Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections: Global health sector strategies 2022-2030. Accessed 30th March, 2026."}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:37:50Z","timestamp":1790152670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/53\/147\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":17,"URL":"https:\/\/doi.org\/10.11604\/pamj.2026.53.147.50389","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"50389"}}